View Older Stories View More Recent Stories
-
Form SC 13G/A Mirati Therapeutics, Filed by: Broadfin Capital, LLC
-
Form SC 13G/A LA JOLLA PHARMACEUTICAL Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Sierra Oncology, Inc. Filed by: Broadfin Capital, LLC
-
Form SC 13G Egalet Corp Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Egalet Corp Filed by: Broadfin Capital, LLC
-
Form SC 13G Aclaris Therapeutics, Filed by: Broadfin Capital, LLC
-
PlacementTracker Publishes 2018 PIPE and Private Placement Markets League Tables
-
Form SC 13G/A ARATANA THERAPEUTICS, Filed by: Broadfin Capital, LLC
-
Form 3 ARATANA THERAPEUTICS, For: Jan 18 Filed by: Broadfin Capital, LLC
-
Form SC 13G Neos Therapeutics, Inc. Filed by: Broadfin Capital, LLC
-
Avadel Pharma (AVDL) Reports Resignation of CEO Michael S. Anderson, Appoints COO Gregory Divis as Interim CEO; Names Geoffrey Glass as Board Chair & Eric Ende to Board
-
Avadel Pharmaceuticals Announces Changes to Management Team and Board of Directors
-
Form 4 NOVELION THERAPEUTICS For: Dec 24 Filed by: Broadfin Capital, LLC
-
Form SC 13G/A NOVELION THERAPEUTICS Filed by: Broadfin Capital, LLC
-
Form 3 AVADEL PHARMACEUTICALS For: Dec 07 Filed by: Broadfin Capital, LLC
-
Form SC 13D AVADEL PHARMACEUTICALS Filed by: Broadfin Capital, LLC
-
Avadel Pharma (AVDL) Announces Kevin Kotler to Board
-
Avadel Pharmaceuticals Appoints Kevin Kotler to the Company’s Board of Directors
-
Form SC 13G/A Corium International, Filed by: Broadfin Capital, LLC
-
Form 4 Corium International, For: Nov 27 Filed by: Broadfin Capital, LLC
-
Form 13F-HR Broadfin Capital, LLC For: Sep 30
-
PlacementTracker Publishes Q3 2018 Private Placement Market League Tables
-
Form SC 13G/A Corium International, Filed by: Broadfin Capital, LLC
-
Form SC 13G Sierra Oncology, Inc. Filed by: Broadfin Capital, LLC
-
Exicure, Inc. Announces Expected Closing of Approximately $22 Million Private Placement Offering
-
Form 13F-HR Broadfin Capital, LLC For: Jun 30
-
Form 4 NOVELION THERAPEUTICS For: Aug 09 Filed by: Broadfin Capital, LLC
-
Form SC 13D/A BIODELIVERY SCIENCES Filed by: Broadfin Capital, LLC
-
PlacementTracker Publishes First Half 2018 PIPE Market League Tables
-
Form SC 13G ADMA BIOLOGICS, INC. Filed by: Broadfin Capital, LLC
-
STRATA Skin Sciences Announces Closing of a $17 Million Equity Financing and the Formal Appointment of New Management to Accelerate Growth and Enrich its XTRAC® Business Strategy
-
Form SC 13G/A Recro Pharma, Inc. Filed by: Broadfin Capital, LLC
-
Form 4 Recro Pharma, Inc. For: May 24 Filed by: Broadfin Capital, LLC
-
Form 3 BIODELIVERY SCIENCES For: May 21 Filed by: Broadfin Capital, LLC
-
BioDelivery Sciences (BDSI) Names Peter Greenleaf as Chairman; Closes $50 Million Equity Financing
-
BioDelivery Sciences Announces Closing of $50 Million Equity Financing and Appointment of Peter Greenleaf as Chairman of the Board
-
BioDelivery Sciences Announces Closing of $50 Million Equity Financing and Appointment of Peter Greenleaf as Chairman of the Board
-
Form SC 13D/A BIODELIVERY SCIENCES Filed by: Broadfin Capital, LLC
-
Pre-Open Movers 05/17: (WWE) (LOXO) (NTES) Higher; (JNCE) (JCP) (ACXM) Lower (more...)
-
BioDelivery Sciences (BDSI) Reports Agreement with Broadfin Capital on Comprehensive Plan to Strengthen Business
-
BioDelivery Sciences Announces Agreement with Broadfin Capital on Comprehensive Plan to Strengthen Business
-
BioDelivery Sciences Announces Agreement with Broadfin Capital on Comprehensive Plan to Strengthen Business
-
Form 13F-HR Broadfin Capital, LLC For: Mar 31
-
Novelion Therapeutics Reports First Quarter 2018 Financial Results
-
Novelion Therapeutics Reports First Quarter 2018 Financial Results
-
BioDelivery Sciences Confirms Receipt of Notice of Intent to Nominate Directors by Broadfin Capital